Kaleido Biosciences Insider Trades

KLDO

Track insider trading activity from Kaleido Biosciences executives and directors. See which insiders are buying and selling KLDO stock.

Trades Last 12 Months

All Insider Trades for Kaleido Biosciences

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Van Hylckama Vlieg Johan Chief Scientific Officer
Holding Value $0.462 4,620 shares
Last Trade
Feb 28, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.11k 2,087 shares
$1.49
$0.00
Korn Jerald COO & General Counsel
Holding Value $0.452 4,517 shares
Last Trade
Feb 28, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.05k 2,046 shares
$1.49
$0.00
Burnett Grady Director
Holding Value $1.5 15,000 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 15,000 shares
$7.44
$0.00
Bassler Bonnie L Director
Holding Value $1.5 15,000 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 15,000 shares
$7.44
$0.00
Bonney Michael W Director
Holding Value $1.5 15,000 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 15,000 shares
$7.44
$0.00
Holding Value $1.5 15,000 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 15,000 shares
$7.44
$0.00
Mixer Jean K Director
Holding Value $1.5 15,000 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 15,000 shares
$7.44
$0.00
Prener Anne Director
Holding Value $1.5 15,000 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 15,000 shares
$7.44
$0.00
Quinn Anthony G. Director
Holding Value $1.5 15,000 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 15,000 shares
$7.44
$0.00
Holding Value $1.5 15,000 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 15,000 shares
$7.44
$0.00
Holding Value $169 1,685,444 shares
Last Trade
Feb 08, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$824k 71,666 shares
$11.50
$0.00
Knobil Katharine Chief Medical Officer
Holding Value $6.75 67,500 shares
Last Trade
Oct 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$587k 67,500 shares
$8.69
$0.00
Lawton Alison Frances See Remarks
Holding Value $11.9 118,500 shares
Last Trade
Apr 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$711k 118,500 shares
$6.00
$0.00
Scalzo Richard William Principal Accounting Officer
Holding Value $0 0 shares
Last Trade
Oct 11, 2019 Sale
$323k 50,000 shares
$6.46
$0.00
Brumm Joshua T See Remarks
Holding Value $8 80,000 shares
Last Trade
Mar 04, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 80,000 shares
$15.00
$0.00
Holding Value $191 1,910,972 shares
Last Trade
Mar 04, 2019 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$9.38M 625,625 shares
$15.00
$0.00
Sculley John Director
Holding Value $0 0 shares
Last Trade
Feb 27, 2019 Sale
No data
No data
$0.00
Holding Value $0 0 shares
Last Trade
Feb 27, 2019 Sale
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up